US Stock MarketDetailed Quotes

ORKA Oruka Therapeutics

Watchlist
  • 9.505
  • -0.755-7.36%
Trading Apr 1 10:25 ET
355.87MMarket Cap-25.01P/E (TTM)

About Oruka Therapeutics Company

Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.

Company Profile

SymbolORKA
Company NameOruka Therapeutics
Listing DateAug 8, 1997
CEODr. Lawrence Otto Klein, PhD
MarketNASDAQ
Employees36
Fiscal Year Ends12-31
Address855 Oak Grove Avenue,Suite 100
CityMenlo Park
ProvinceCalifornia
CountryUnited States of America
Zip Code94025
Phone1-650-606-7910

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Lawrence Otto Klein, PhD
  • Director, President and Chief Executive Officer
  • 520.91K
  • Dr. Joana Goncalves, M.D.
  • Chief Medical Officer
  • 317.99K
  • Arjun Agarwal
  • Senior Vice President, Finance and Treasurer
  • --
  • Dr. Samarth Kulkarni, PhD
  • Chairman of the Board
  • 27.74K
  • Kristine M. Ball
  • Independent Director
  • 20.55K
  • Peter Harwin
  • Independent Director
  • 19.18K
  • Dr. Carl Dambkowski, M.D.
  • Independent Director
  • 16.27K
  • Dr. Cameron Turtle, D.Phil.
  • Independent Director
  • --
  • Paul T. Quinlan PhD
  • General Counsel and Corporate Secretary
  • 310.45K

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More